You are here

P&T News

May 23

Combination product consists of Tresiba and Victoza
Entresto and Corlanor added to list of treatments
National Eye Institute report identifies trends by race, ethnicity, and gender
Decellularized vascular grafts will be studied in dialysis patients with ESRD

May 20

Generic companies aren’t required to update safety labeling
Company revises tens of thousands of analyses
SGLT2 inhibitor is available as Invokana and Invokamet
New sensor technology could be in clinics next year
Diazepam spray doesn’t measure up to rectal gel

May 19

First PD-L1 inhibitor to garner agency approval
Product is first myeloma-targeted monoclonal antibody approved in U.S.
Results expected in 2020
Doctors’ errors kill hundreds of thousands of people in U.S. each year
Worldwide death toll could reach 10 million by 2050, report warns

May 18

House GOP bill cuts price tag in half
Industry leaders give “thumbs down” to patient-friendly quality indicator
Opioid death rate increased by 86% between 2009 and 2015, researchers find
Analysts see new data as major milestone
Phase 3 study halted early after drug improves progression-free survival

Pages